| 3/29/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO -DRUG | XXXXXXXXXX | 3 | UNIT | 237 | BELGIUM | NA |
| 3/29/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO -DRUG | XXXXXXXXXX | 4 | UNIT | 306 | BELGIUM | NA |
| 3/28/2024 | 300693000000 | ROCATİNLİMAB (AMG 451) 150MG/ML/,PLACEBO/, 2ML,VIAL, 2 UNITS/KIT-DRUG | XXXXXXXXXX | 3 | UNIT | 980 | JAPAN | NA |
| 3/28/2024 | 300693000000 | ROCATİNLİMAB (AMG 451) 150MG/ML/,PLACEBO/, 2ML,VIAL, 2 UNITS/KIT-DRUG | XXXXXXXXXX | 9 | UNIT | 3933 | JAPAN | NA |
| 3/27/2024 | 300693000000 | ONE KIT CONTAINING PLACEBO (15MG/TABLET /(DRUG WITHOUT ACTIVE INGREDIENT) [GZ402671] | XXXXXXXXXX | 7 | UNIT | 688 | FRANCE | NA |
| 3/27/2024 | 300693000000 | 1 VIAL PLACEBO TO CROVALİMAB 340 MG / 2 /ML (DRUG) | XXXXXXXXXX | 70 | UNIT | 1638 | USA | NA |
| 3/26/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO------DRUG | XXXXXXXXXX | 4 | UNIT | 306 | BELGIUM | NA |
| 3/26/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO------DRUG | XXXXXXXXXX | 2 | UNIT | 168 | BELGIUM | NA |
| 3/26/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO------DRUG | XXXXXXXXXX | 3 | UNIT | 237 | BELGIUM | NA |
| 3/25/2024 | 300693000000 | LY3298176 AI 2.5MG 5MG 7.5MG 10MG 12.5MG/ 15MG OR PBO--DRUG | XXXXXXXXXX | 2 | UNIT | 168 | BELGIUM | NA |